Cite
HARVARD Citation
Reich, K. et al. (2021). Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2. British journal of dermatology. pp. 1146-1159. [Online].